Table 1C. Distribution of induction and maintenance immunosuppressants.
N (%) | N (%) | N (%) | N (%) | N (%) | ||
---|---|---|---|---|---|---|
INDUCTION | TOTAL | Thymo | Campath | None | ||
Training set | Pre-transplant | 49 (100) | 29 (59.2) | 10 (20.4) | 10 (20.4) | |
Validation set | Pre-transplant | 33 (100) | 19 (57.5) | 1 (3) | 13 (39.4) | |
p-value* | 0.999 (NS) | 0.043 | 0.080 (NS) | |||
Training set | Post-transplant | 98 (100) | 54 (55.1) | 11 (11.2) | 33 (33.7) | |
Validation set | Post-transplant | 64 (100) | 32 (50) | 3 (4.7) | 29 (45.3) | |
p-value* | 0.629 (NS) | 0.252 (NS) | 0.142 (NS) | |||
MAINTENANCE | Tacrolimus | Steroids | Cellcept | Rapamycin | ||
Training set | Post-transplant | 98 (100) | 91 (92.8) | 36 (36.7) | 4 (4.1) | 5 (5.1) |
Validation set | Post-transplant | 64 (100) | 61 (95.3) | 29 (45.3) | 0 (0) | 2 (3.1) |
p-value* | 0.741 (NS) | 0.326 (NS) | 0.154 (NS) | 0.705 (NS) |
p-value Fisher exact test